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Abstract 
Substantial rates of substance use comorbidity have been observed among veterans with PTSD 
highlighting the need to identify patient and program characteristics associated with improved 
outcomes for substance abuse. Data were drawn from 12,270 dually diagnosed veterans who 
sought treatment from specialized intensive Veterans Health Administration PTSD programs 
between 1993 and 2011. The magnitude of the improvement in Addiction Severity Index (ASI) 
alcohol and drug use composite scores from baseline was moderate, with effect sizes (ES) of -.269 
and -.287, respectively. Multivariate analyses revealed that treatment in longer-term programs, 
being prescribed psychiatric medication, and planned participation in reunions were all associated 
with slightly improved outcomes. Reductions in substance use measures were associated with 
robust improvements in PTSD symptoms and violent behavior. These findings suggest not only 
synergistic treatment effects linking improvement in PTSD symptoms with substance use 
disorders among dually diagnosed veterans with PTSD but also to improvement in violent 
behavior. Furthermore, the findings indicate that proper discharge planning in addition to intensity 
and duration of treatment for dually diagnosed veterans with severe PTSD may result in better 
outcomes. Further dissemination of evidence-based substance abuse treatment may benefit this 
population. 
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INTRODUCTION 
Many veterans who suffer from Post-Traumatic Stress Disorder (PTSD) also experience 
comorbid substance use (Jacobsen, Southwick, & Kosten, 2001). Although conclusive data on 
causal relationships are not available (Fontana, Rosenheck, & Desai, 2012), there is clear 
empirical evidence showing the association  of PTSD with poorer substance use outcomes 
(Jacobsen et al., 2001) with some studies indicating that trauma cues increased cravings for 
addictive substances (Coffey et al., 2002; Saladin et al., 2003). The combination of PTSD and 
substance use is associated with especially complex clinical challenges because of the adverse 
synergies of addictive disorders and PTSD (Back, Waldrop, & Brady, 2009; van Dam, Ehring, 
Vedel, & Emmelkamp, 2013).  
Some studies suggest that dually diagnosed PTSD patients have worse outcomes than 
those with either diagnosis alone including higher rates of substance-related relapses and 
substance-related hospital admissions, more severe PTSD symptoms, shorter periods of 
abstinence, and poorer adherence to follow-up treatment (Brown, Read, & Kahler, 2003; Paige 
Ouimette, Moos, & Brown, 2003; Schafer & Najavits, 2007). Furthermore, dually diagnosed 
PTSD patients report greater efforts to obtain illicit substances, higher likelihood of use to the 
point of intoxication, higher levels of substance use in response to negative interpersonal 
emotions (P. Ouimette, Coolhart, Funderburk, Wade, & Brown, 2007), and poorer physical 
health outcomes (P. Ouimette, Goodwin, & Brown, 2006). However, other studies suggests that 
patients with co-morbid substance use treated in specialized intensive treatment programs may 
show greater improvement in PTSD symptoms than veterans without substance use co-
morbidity, apparently due to reduced substance use  through such treatment (Fontana et al., 
2012). With high rates of comorbid PTSD and substance use among war zone veterans, the 
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Department of Veterans Affairs has devoted considerable resources to help these veterans 
(Bohnert et al., 2013; Fontana & Rosenheck, 1997).  
Studies have suggested that among dually diagnosed veterans with PTSD, comprehensive 
care targeted to treat substance abuse comorbidity may lead to significant reductions in PTSD 
symptoms (Hien et al., 2010). Consistent with this suggestion, one large scale Veterans Health 
Administration (VHA) study found that veterans admitted into VHA specialized 
inpatient/residential PTSD programs with co-morbid PTSD and substance use disorder showed 
greater improvement, albeit modest in magnitude, in PTSD symptoms than veterans with PTSD 
without a comorbid substance use disorder (Fontana et al., 2012). These findings were most 
likely attributed to improvement in substance use disorders being associated with greater 
improvement in PTSD symptoms after discharge  (Fontana et al., 2012).   
Despite encouraging outcomes found in these studies, no specific pharmacotherapies or 
psychotherapies have been clearly demonstrated to improve substance use outcomes among 
individuals with PTSD (van Dam et al., 2013) with limited exceptions (P. Ouimette, Moos, & 
Finney, 2003; Petrakis et al., 2006; Possemato et al., 2012). This lack of specific demonstrably 
effective treatments is even more concerning since large numbers of veterans are now returning 
home from war in the middle east with high rates of PTSD and associated substance abuse 
problems (Jacobson et al., 2008; Stecker, Fortney, Hamilton, Sherbourne, & Ajzen, 2010). 
Previous research has highlighted the need for studies to identify factors responsible for the 
synergistic treatment effects linking improvement in PTSD symptoms with improvement in 
substance use disorders (Fontana et al., 2012). Studies have found that over time substance 
dependence and PTSD symptoms co-vary concurrently (P. Ouimette, Read, Wade, & Tirone, 
2010). Furthermore, greater severity of the traumatic exposure can negatively impact substance 
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use outcomes (Read et al., 2012). However, to the authors’ knowledge, no paper has 
systematically identified predictors or correlates of improvement in substance abuse among 
veterans with PTSD and comorbid substance abuse in real-world clinical settings. Moreover, 
with the rising demand for services among veteran personnel returning home from the middle 
east (Hermes, Rosenheck, Desai, & Fontana, 2012) and published concerns about the cost of 
caring for them (Bilmes & Stiglitz, 2008) studies are needed that identify treatment elements 
associated with positive substance use outcomes (Rosenheck & Fontana, 2001).  
From1992 to 2011, the VHA used a consistent system to monitor veteran outcomes in its 
specialized intensive inpatient, residential, and day treatment programs for veterans with PTSD 
(Fontana & Rosenheck, 2008). In this exploratory study, we examined data from a large cohort 
of veterans with comorbid PTSD and substance abuse treated in these programs to identify 
baseline characteristics, program characteristics, and features of their status at the time of 
discharge that are associated with improvement in substance abuse outcomes four months after 
discharge. In addition, we examined the association of reduction in alcohol and drug use 
problems with improvement with other outcomes such as employment, PTSD, and violent 
behavior. This study thus seeks to illuminate veteran characteristics and treatment elements 
associated with superior outcomes of comorbid substance abuse among dually diagnosed 
veterans with PTSD. This study also attempts to further elucidate the association of improvement 
in substance abuse with other important outcomes among veterans whose problems are severe 
enough to require intensive treatment. Identification of such characteristics and treatment 
elements in this high risk population may suggest areas for future treatment development and 
dissemination.           
METHOD 
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Participants 
Data were drawn from administrative evaluation data collected by the VA’s Northeast 
Program Evaluation Center (NEPEC) on all veterans who sought treatment from specialized 
intensive PTSD programs between 1993 and 2011. The number of sites vary from year to year 
due to programs closing or being converted to non-intensive treatment programs. On an annual 
basis, there were between 33 and 53 programs included in the program evaluation initiative. The 
cohort for this analysis was limited to patients diagnosed with both PTSD and Alcohol or Drug 
Use Disorders (N=12, 270).       
Measures 
Measures available from the specialized PTSD program monitored variables such as 
socio-demographic characteristics, clinical diagnoses, severity of clinical status as measured by 
standardized scales, treatment program characteristics, and discharge status (i.e. successfully 
completed the program, left prematurely or left following program rule violations). Outcomes 
were measured as changes from the admission assessment to four months after discharge based 
on continuous measures of substance use, PTSD symptoms and other clinical variables.  
Variables which assessed baseline clinical status included clinical diagnoses of alcohol use 
disorders, drug use disorders and other Axis I and/or Axis II diagnoses comorbid with PTSD. In 
addition VA service connected disability status for PTSD, for psychiatric disorders other than 
PTSD, and for non-psychiatric medical disorders were all documented at the time of program 
entry along with severity of drug and alcohol use, PTSD symptoms, current medical  problems, 
and recent violent behavior. 
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Clinical status was measured by the Short Form of the Mississippi Scale for PTSD 
(MISS) (Fontana & Rosenheck, 1994) (range = 15 – 55) which was developed to assess combat 
related PTSD symptoms. These symptoms include avoiding reminders of the war, symptoms of 
irritability, feeling numb and emotionally distant from others, sleep disturbances, intrusive 
thoughts, flashbacks and nightmares, and hyperarousal. Research has shown the coefficient alpha 
for the MISS between .83 and .96 (Fontana & Rosenheck, 1994; T. M. Keane, Caddell, & 
Taylor, 1988). Composite indices from the Addiction Severity Index (ASI) (McLellan et al., 
1985) were used to assess alcohol and drug use.  Studies have shown the average concordance 
rates for the ASI to be as high as .89 (McLellan et al., 1985). Violent behavior was assessed by 
averaging 4 items from the National Vietnam Veterans Readjustment Study (Kulka, 1990) (range 
= 0 – 4).  Employment was measured as the number of days employed during the past 30 days. 
Treatment programs were characterized as one of four program types to which veterans 
were admitted: 1) Evaluation/Brief Treatment PTSD Units (EBTPUs), short term units with 
lengths of stay (LOS) targeted at less than 14 days which typically offer  acute stabilization, 
PTSD evaluation, psycho-education, medical assessment, psychotropic medication and brief 
supportive psychotherapy; 2) Specialized Inpatient PTSD Units (SIPUs), with LOS of 28-90 
days  or longer which typically include acute hospital care, intensive trauma-focused evaluation, 
education, and intensive group and individual psychotherapy along with medical assessment and 
psychotropic medication; 3) PTSD Residential Rehabilitation Programs (PRRPs), with LOS 
similar to SIPUs but is less intensively supervised, and are less medically-oriented “halfway-
house” settings offering  PTSD evaluation, psycho-education, group and individual 
psychotherapy and counseling, and case management with an emphasis on resuming productive 
involvement in community life; and 4) Day Hospital PTSD Programs, which are “therapeutic 
INTENSIVE TREATMENT FOR DUALLY DIAGNOSED VETERANS                             7 
 
 
communities” similar to PRRPs where veterans can engage in counseling, social, recreational, 
and vocational activities several times a week but reside in the community in their usual 
residence or in a “residential” program  elsewhere within the VHA facility.   
Status at discharge documented the veteran’s reason for leaving the program as assessed 
by their primary treatment provider, which included: 1) a mutually agreed upon discharge plan 
between the staff and patient (successful program completion); 2) the veteran initiated choice to 
leave the program on his/her own; 3) veteran departed for reasons related to rule violations such 
as substance abuse or violent behavior; or 4) whether the veteran was deemed by staff to be too 
sick to continue in the program.  Discharge status was further assessed by tracking each veteran’s 
disposition which included: 1) being sent to another institution/program for further treatment; 2) 
to his/her own residence; or 3) to share someone else’s residence in the community. Veterans 
were also asked about their expectations for employment post-discharge.    
Several measures documented at admission and discharge represented program 
participation: LOS in the program, direct transfer into the program from the community (as 
contrasted to transfer from another program), level of reported commitment to the program 
(reflecting clinician judgment on a 0-4 scale at the time of discharge), and plans to participate in 
program “reunions” for post-discharge support. 
Analyses     
First, a bivariate correlation table was constructed to identify the associations between 
changes in alcohol and drug use status and individual sociodemographic characteristics, 
psychiatric diagnoses, clinical status variables, program characteristics, and discharge status 
indicators, controlling for potentially confounding baseline clinical status measures including 
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severity of alcohol and drug use, violent behavior, PTSD symptoms, and employment, using 
linear regression. Thus, bivariate relationships were assessed net of major baseline clinical status 
indicators. In addition, the association of change from baseline to follow-up on substance abuse 
measures was examined in relationship to change in other outcomes including PTSD symptoms, 
violent behavior, and days of employment. Based on the large number of statistical variables 
being assessed and the large sample size, a stringent alpha level of .001 was adopted to test for 
statistical significance.  
Next, stepwise linear regression including all variables significant on bivariate analysis 
was used to determine which baseline variables were the strongest independent predictors of 
changes in alcohol and drug use severity, again controlling for baseline measures of alcohol and 
drug use and PTSD symptom severity.  These analyses established a parsimonious set of 
independent baseline correlates of change in alcohol and drug use indicators net of baseline 
status on other clinical status measures. 
Multivariate analysis was then conducted to examine the association of change in alcohol 
and drug use indicators with change in other clinical variables of interest (PTSD symptoms, 
violent behavior, and employment) net of baseline characteristics found to be significant in the 
previous analyses. Changes in days of employment, violence and two measures of PTSD were 
examined in a separate set of multivariate analysis in order to prevent these variables from 
confounding the analysis of the effect of baseline and treatment element predictors. Again 
because of the large sample size vastly enhancing statistical power, a standardized regression 
estimate of .02 was used as the threshold value for meaningful associations.      
RESULTS 
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General characteristics of the sample 
The sample consisted of 12, 270 veterans with an average age of 50.2 years (SD= 8.7) 
(Table 1). A majority of the sample had an Alcohol Abuse/Dependence diagnosis (91%), 
followed by Drug Abuse/Dependence (60%) (51% had both alcohol and drug 
Abuse/Dependence), an Affective Disorder (33%), or an Anxiety Disorder diagnosis (14%) other 
than PTSD. On average, veterans in this sample had an average of 3.1 psychiatric co-morbid 
diagnoses (SD= 1.0), which included a diagnosis of PTSD. The average length of stay in these 
programs was 51.4 days (SD= 32.9 days).  
Bivariate changes in ASI alcohol abuse and ASI drug abuse composite scores 
At baseline, the mean ASI alcohol score was .22 (SD= .27) and the mean ASI drug score 
was .09 (SD= .12). The magnitude of the improvement in ASI alcohol abuse composite scores 
from baseline was small to moderate with an effect size (ES) of -.269. The magnitude of the 
improvement in ASI drug abuse composite scores from baseline was also small to moderate (ES 
= -.287). Bivariate correlation analysis identified several variables that were associated with 
change (improvement) in the ASI alcohol and ASI drug composite indices controlling for 
measures of baseline clinical status (Table 1). In these analyses, positive coefficients represent an 
association with increased substance abuse and a negative association with decreased substance 
use. Age (t= -3.55, β = -.022, p< .001) and being prescribed psychiatric medication in the past 30 
days (t= -3.79, β = -.023, p< .001) were both associated with a significant, albeit small, decrease 
in ASI alcohol severity. Age was also associated with a significant decrease in ASI drug severity 
(t= -4.48, β = -.026, p< .001). However, a history of incarceration was associated with a relative 
increase in ASI drug severity (t= 4.19, β = .025, p< .001). Among the co-morbid psychiatric 
INTENSIVE TREATMENT FOR DUALLY DIAGNOSED VETERANS                             10 
 
 
diagnoses, drug abuse/dependence was associated with a significant relative reduction (t= -5.83, 
β = -.037, p< .001) in ASI alcohol severity whereas an alcohol abuse/dependence diagnosis was 
related to a significant relative increase (t= 4.98, β = .032, p< .001). Alcohol abuse/dependence 
was associated with a significant relative reduction (t= -5.19, β = -.033, p< .001) in ASI drug 
severity while a drug abuse/dependence diagnosis (t= 10.42, β = .063, p< .001) and total number 
of diagnoses (t= 5.16, β = .030, p< .001) were related to a significant increase in ASI drug 
severity. Length of stay in the program (t= -4.86, β = -.029, p< .001), direct transfer into the 
program from another program (t= -4.23, β = -.027, p< .001) were significantly associated with a 
reduction in ASI alcohol severity but not for ASI drug severity. Level of reported commitment to 
the program (t= -5.23, β = -.031, p< .001) and planned participation in reunions (t= -8.09, β = -
.048, p< .001) were significantly associated with a reduction in ASI alcohol severity and a 
reduction in ASI drug severity (t= -3.88, β = -.022, p< .001) and (t= -7.01, β = -.040, p< .001), 
respectively.  
In comparison to the veterans in the short-term EBTPUs (the reference condition), 
veterans in the SIPUs (t= -3.91, β = -.031, p< .001) and in PRRPs (t= -3.57, β = -.032, p< .001) 
demonstrated significant relative improvements in ASI alcohol severity in bivariate analysis. 
Similarly, veterans admitted to SIPUs (t= -3.37, β = -.026, p< .001) and PRRPs (t= -3.89, β = -
.034, p< .001) demonstrated significant relative improvements in ASI drug severity.  With regard 
to discharge status, only being transferred to another program was significantly associated with a 
reduction in ASI alcohol severity. In comparison to veterans who were discharged to another 
program or institution, veterans who were discharged to their own residence (t= 5.95, β = .046, 
p< .001) or to share someone else’s residence (t= 5.72, β = .042, p< .001) showed significant 
relative increases in ASI alcohol severity, most likely because they had more opportunities for 
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substance use at those residences. Similarly, veterans who were discharged to someone else’s 
residence showed significant increases (t= 3.39, β = .024, p< .001) in ASI drug severity, again 
potentially due to greater availability of drugs. Veterans who chose to leave the program without 
staff concurrence demonstrated significantly poorer ASI alcohol severity outcomes (t= 3.53, β = 
.021, p< .001) than veterans who had a mutually agreed upon a discharge plan with staff. 
Veterans who left the program for reasons associated with rule violations demonstrated 
significantly poorer ASI alcohol severity outcomes (t= 6.07, β = .036, p< .001) and poorer ASI 
drug severity outcomes (t= 7.05, β = .040, p< .001) than veterans who had a mutually agreed 
upon a discharge plan with staff. Plans for employment post-discharge were also associated with 
significant relative reductions in ASI alcohol severity (t= -2.78, β = -.017, p< .001).  
There was a significant positive relationship between reduction in violence with ASI 
alcohol reduction (t= 25.66, β = .199, p< .001) and with ASI drug reduction (t= 21.33, β = .161, 
p< .001). The mean Short Mississippi PTSD score was 40.2 (SD= 5.6) and the changes revealed 
an overall moderate effect size (ES = .46). The Short Mississippi PTSD scores were significantly 
associated with ASI alcohol reduction (t= 24.37, β = .142, p< .001) and ASI drug reduction (t= 
17.95, β = .102, p< .001). These findings mean that as alcohol and drug problems declined so did 
PTSD symptoms and violent behavior. There were no significant associations between ASI 
alcohol or drug severity with changes in days of employment. 
Stepwise multiple linear regression analyses predicting ASI alcohol and drug composite score 
changes 
The stepwise linear regression revealed several baseline variables that were significant 
independent predictors of ASI alcohol and drug change (Table 2). Being prescribed psychiatric 
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medication in the past 30 days was associated with small reductions in ASI alcohol severity 
scores from baseline. Planned participation in reunions and enrollment in either the SIPUs or 
PRRPs were associated with significant reductions in ASI alcohol and ASI drug severity scores 
from baseline. However, discharge associated with rule violations or discharge to one’s own 
place or someone else’s place were all associated with a significant relative increase in ASI 
alcohol and ASI drug severity scores from baseline. A history of incarceration was associated 
with a significant relative increase in ASI drug severity scores, but not ASI alcohol scores, from 
baseline. Further, a separate stepwise linear regression confirmed that reductions in alcohol and 
drug use were positively associated with reductions in violence and PTSD symptoms as 
measured by the Short Form of the Mississippi Scale for PTSD and these were the strongest 
observed associations.  
DISCUSSION 
 This study of a large sample of veterans with severe PTSD requiring specialized intensive 
treatment, examined baseline and programmatic correlates of improvement in substance use and 
concurrent changes between substance use and in other important outcomes. Previous studies 
have demonstrated high rates of comorbidity between PTSD and substance use disorders 
(Terence M. Keane & Wolfe, 1990) and the additive negative effects of additional Axis I 
diagnoses on their psychopathology (Cacciola, Koppenhaver, Alterman, & McKay, 2009). These 
prior studies highlight the synergistic adverse relationship between trauma and substance use and 
the need for research to identify effective programs and/or related factors targeted to address this 
area of critical importance.  In our multivariate analysis, several program participation indicators 
had significant, albeit small, associations with substance abuse outcomes. Treatment in longer 
term programs (PRRPs and SIPUs) with longer lengths of stay, being prescribed medication, and 
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planned participation in program reunions were associated with slightly improved alcohol 
outcomes. Similar results were found for illicit drug use measures with the exception that total 
number of diagnoses and prior history of incarceration were related to poorer outcomes. 
Although the effect sizes in our study were small to moderate, research shows that effect sizes 
observed in real word observational studies are generally smaller than those seen in highly 
controlled clinical studies, or observational studies in which the service providers are specifically 
trained in delivery of the intervention and monitored for treatment fidelity (Eftekhari et al., 2013; 
Karlin et al., 2010).  
Examination of clinical correlates of substance use change showed far stronger 
associations such that as alcohol and drug composite scores improved, reductions were also 
observed in violent behavior and PTSD symptoms. Research has documented the symptom 
improvement in specialized intensive VHA programs for veterans with PTSD however, 
comparisons between the long term units and the short term units have yielded mixed results 
(Fontana & Rosenheck, 1997; Rosenheck, Fontana, & Errera, 1997). The findings from the 
current study are generally consistent with past research. This study revealed greater efficacy for 
the longer term PTSD programs than shorter term ones and an association of length of stay with 
reduced alcohol and drug use indicators on bivariate analysis, suggesting that length of stay may 
mediate the benefits of treatment in SIPUs and PRRPs. Prior studies comparing long term and 
short term residential treatment programs for dual diagnosis patients have also found that 
patients in long term programs had significantly better outcomes which included enhanced 
treatment engagement and maintained abstinence from substances (Brunette, Drake, Woods, & 
Hartnett, 2001). However, improvement may be more influenced by overall treatment duration 
and intensity as contrasted with specific length of stay in the residential component of treatment.  
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We do not have enough detail on services delivered in SIPUs and PRRTPs to determine whether 
the critical element is length of stay, concomitant treatment intensity, or specific treatment 
elements.  
Our study also revealed that in comparison to those discharged based on a mutually 
agreed upon plan between staff and the patient, those discharged under less desirable 
circumstances had poorer substance use outcomes. It is unclear whether the availability of a 
well-worked out treatment plan in itself improves substance use outcomes, or whether this is a 
proxy for other critical factors such as the veteran’s motivation to reduce their substance use, or 
previous degree of benefit from program participation up to the time of discharge.  We also 
found that veterans discharged to another institution had better outcomes that veterans 
discharged to their own homes in the community or to someone else’s residence. This finding 
allows a more straightforward interpretation as greater substance use among veterans discharged 
to community settings, as contrasted to institutions (institutions that are likely to have rules 
forbidding substance use and staff to supervise these rules, as well as a stronger patient-
maintained culture of abstinence) may provide veterans with extra time to develop the skills and 
confidence necessary for prolonged sobriety (Brunette et al., 2001; Rosenheck & Fontana, 2001). 
This point cannot be understated because once patients leave a treatment program they will again 
have greater exposure to sources of alcohol and illicit substances as well as to peers who may 
encourage substance use.   
 This is the first study we know of that examined data from a large cohort of veterans in 
specialized intensive treatment programs over an extended period to identify baseline and 
program characteristics associated with improvement in substance abuse outcomes, employment, 
PTSD, and violent behavior. Our findings are consistent with existing literature documenting that 
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improvements in substance abuse are associated with reductions in PTSD symptoms (Fontana et 
al., 2012). The findings from this study also revealed that among veterans diagnosed with PTSD 
severe enough to warrant specialized intensive treatment, improvement in substance use was 
associated with reductions in violent behavior. These results are largely consistent with literature 
regarding the strong connection between substance use, PTSD, and the perpetration of violence 
(Barrett, Mills, & Teesson, 2011; Barrett, Teesson, & Mills, 2014). Our findings are also 
consistent with the more general association of violence with co-morbid substance use and 
mental illness, even among recently discharged inpatients (Steadman et al., 1998).   
 There are several limitations to this study that require comment. First, the current data is 
associational and based on a specialized group. Thus we cannot ascertain whether the PTSD 
preceded the substance use or vice versa. However, prior research suggests that traumatized 
individuals may turn to illicit substances in an attempt to self-medicate due to the calming effects 
of the substances (Jacobsen et al., 2001; P. Ouimette et al., 2010). Furthermore, studies have 
shown that traumatic symptoms are associated with subsequent risk for substance use (P. 
Ouimette et al., 2003; Read et al., 2012). Given the complex nature of the synergistic effects of 
trauma and substance use, studies stress the need for on-going research to examine the best 
interventions for dually-diagnosed PTSD patients (Hruska, Fallon, Spoonster, Sledjeski, & 
Delahanty, 2011). Another limitation is the lack of available information on the use of treatment 
elements such as the specific evidence-based psychotherapies that may have been offered and 
specific medications or medication classes that were prescribed. This limited our ability to 
identify specific interventions that may have been associated with increased clinical benefit. 
However, as noted in prior research studies of this type, VA administrative databases often do 
not provide specific details on the exact content of therapeutic sessions and applied interventions 
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and identification of specifically effective interventions should be the focus of future studies (P. 
Ouimette et al., 2003).  Also, the design of this study made examining cohort effects difficult to 
evaluate. By examining the linear effect of the year, the data revealed that veterans experienced 
an overall slight improvement in outcomes over the years. However, the population changed 
over the years which can impact outcomes and treatment may have changed in the various 
programs over time and we do not have documentation how it changed from facility to facility 
over time.  Furthermore, this was an observational study such that participants were not 
randomly assigned either to the various treatment programs or to receive specific treatments. Our 
findings are associational which limits casual inferences about the impact of specific treatment 
elements or programs. We attempted to address this limitation to the extent possible by adjusting 
our multivariate analyses to control for potentially confounding baseline factors.  
Despite these limitations, the current study was based on data collected over many years 
from a comprehensive national set of VHA programs designed to treat the most seriously ill 
veterans with PTSD and co-morbid substance use disorders -- veterans who are in need of 
treatment in specialized intensive (mostly inpatient or residential) programs. We were able to 
identify some treatment elements associated with small, but significant, improvements in 
drug/alcohol use and important clinical correlates of improvement on measures of violence and 
PTSD symptoms.  
This study thus confirms previous research (Fontana et al., 2012) emphasizing the 
importance and broad benefits of improving substance abuse outcomes among dually diagnosed 
veterans with PTSD and draws attention to the need to develop and disseminate more effective 
treatments for this population. While there have been extensive efforts in VHA to disseminate 
evidence –based treatments for PTSD in recent years (Eftekhari et al., 2013; Karlin et al., 2010) 
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there has been far less research on the use and dissemination of psychotherapies for co-morbid 
substance use disorders in PTSD. Treatments such as contingency management (Higgins, 
Silverman, & Heil, 2008), cognitive behavioral therapy (Beck, 1999; Wright, 2001), 
motivational interviewing (Martino, Carroll, Kostas, Perkins, & Rounsaville, 2002; Martino, 
Carroll, O'Malley, & Rounsaville, 2000) and computerized therapies for substance use disorders 
(Carroll et al., 2008) may all have a role in the treatment of substance use in dually diagnosed 
patients with PTSD in specialized intensive PTSD programs.  Further studies of effective 
medications (Sofuoglu, Rosenheck, & Petrakis, 2014) and of combinations of medications and 
psychotherapies (Roman, Abraham, & Knudsen, 2011) are also needed. This study emphasizes 
the need for and potential benefits of research and dissemination efforts to provide more 
effective substance abuse treatments for this especially vulnerable population of veterans with 
specialized treatment needs.  
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